Peptide Synthesizers Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Peptide Synthesizers Market By Application (Vaccines, Oncology, and Others), By Product (Reagents and Peptide Synthesizers), By End User (Pharmaceutical and Biotechnology Companies, CDMO/CRO, and Academic Research Institutes), and Geography 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Peptide Synthesizers Market size was valued at USD 371.92 million in 2021 and is anticipated to grow to USD 581.78 million by 2028 growing at a CAGR of 6.6% during the forecast period 2022-2028. Peptide Synthesizers Market is chains of amino acids that make up the basic building blocks of all living things. Individual amino acids can be used to make in-vitro peptides, which are subsequently bound according to their desired sequence in a highly regulated environment. Previously, synthetic peptides were manufactured using the liquid phase method, which has mostly been replaced by the solid phase method. Prior to the introduction of peptide synthesiser devices, in-vitro peptide synthesis was a time-consuming process requiring a lot of resources, highly skilled operators, and a lot of complexity. Peptide synthesisers provide the capacity to synthesise and create complex peptides in a short amount of time, from the research stage through the manufacturing stage. Furthermore, modern peptide synthesisers are capable of simultaneously synthesising numerous peptides. Synthetic peptides are used in the research and design of enzymes, vaccines, and medicines, as well as to manufacture specific antibody epitopes and enzyme-binding sites. Over the forecast period of 2021 to 2027, this is projected to propel the global market for peptide synthesisers. Furthermore, the growing preference in the pharmaceutical sector for peptide therapies and biosimilars is expected to boost the market. Rising viral and parasite infections around the world, as well as the incidence of other chronic diseases, are projected to increase demand for cutting-edge diagnostic technologies that use specific antibodies. In vitro peptide synthesis is predicted to increase as a result, fueling the global market for peptide synthesisers in the coming years.

 

 

Peptide Synthesizers Market

MARKET SUMMARY
-
6.6%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 6.6%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Peptide Synthesizers Market

  • The report on global market gives historical, current, and future market sizes (US$ Mn) on the basis of application, product type end user, and region.
  • Key stakeholders of the global peptide synthesizers market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global peptide synthesizers products.
Key Players
  • CS Bio Company, Inc.
  • Biotage AB
  • AAPPTec
  • CEM Corporation
  • Activotec
Peptide Synthesizers Market Growth

Increase in the prevalence of chronic diseases such as diabetes, cancer, and obesity and growing number of biopharmaceutical and pharmaceutical companies are the major factors boosting the revenue growth of the global peptide synthesizers market. Apart from aforementioned dynamics, peptides are highly active and highly specific drug substances and increasing used as potential active pharmaceutical ingredients due to their high biological activity, high specificity, large chemical space, ready availability, and low toxicity propel the global peptide synthesizers market over the forecast years.Peptide Synthesizers Market increase in research activities and availability of funding for R&D and growing use of peptides in pharmaceutical drugs and increasing prevalence of chronic diseases such as diabetes, cancer, and obesity are the major factors that are driving the growth of the peptide synthesizers market.


North-America Got Significant Share

Peptide Synthesizers Market

peptide synthesizers market report gives comprehensive outlook on peptide synthesizers across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America accounted for larger revenue share in global peptide synthesizers market with significant CAGR. Presence of large number of prominent market players and advancements in technology and adoption of new technology boost the market in the region. Additionally, increasing investments by the pharmaceutical and biotechnology companies and rising research and development activities in the region fuels the growth of the market. Europe and Asia Pacific are expected to significant growth rate over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Peptide Synthesizers Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The peptide synthesizers market is projected to expand at a CAGR of 6.6% during the forecast period.

CS Bio Company, Inc., Biotage AB, Gyros Protein Technologies AB, AAPPTec, CEM Corporation, Intavis Bioanalytical Instruments AG

Asia Pacific is the fastest-growing region for peptide synthesizers market


Report

Table Of Content

1. Executive Summary
2. Global Peptide Synthesis Market Introduction
2.1. Global Peptide Synthesis Market – Taxonomy
2.2. Global Peptide Synthesis Market –Definitions
2.2.1. Application Type
2.2.2. Product Type
2.2.3. End User
2.2.4. Region
3. Global Peptide Synthesis Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Peptide Synthesis Market Dynamic Factors – Impact Analysis
4. Global Peptide Synthesis Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Peptide Synthesis Market, By Application Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Vaccines
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Oncology
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Others
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Peptide Synthesis Market Forecast, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Peptide Synthesizers
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Reagents
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Peptide Synthesis Market, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. Pharmaceutical and Biotechnology Companies
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Contract Development and Manufacturing Organisation/ Contract Research Organisation
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Academic and Research Institutes
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Peptide Synthesis Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Peptide Synthesis Market – Opportunity Analysis Index, By Application, Product, End User, and Region, 2022 – 2028
9. North America Peptide Synthesis Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Vaccines
9.1.2. Oncology
9.1.3. Others
9.2. Product Type Analysis, 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Peptide Synthesizers
9.2.2. Reagents
9.3. End User Type Analysis, 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Pharmaceutical and Biotechnology Companies
9.3.2. Contract Development and Manufacturing Organisation/ Contract Research Organisation
9.3.3. Academics and Research Institutes
9.4. Country Analysis 2017 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Peptide Synthesis Market – Opportunity Analysis Index, By Application, Product Type, End User, and Country, 2022 – 2028
9.6. North America Peptide Synthesis Market Dynamics – Trends
10. Europe Peptide Synthesis Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Vaccines
10.1.2. Oncology
10.1.3. Others
10.2. Product Type Analysis, 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Peptide Synthesizers
10.2.2. Reagents
10.3. End User Type Analysis, 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Pharmaceutical and Biotechnology Companies
10.3.2. Contract Development and Manufacturing Organisation/ Contract Research Organisation
10.3.3. Academics and Research Institutes
10.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Europe Peptide Synthesis Market – Opportunity Analysis Index, By Application, Product Type, End User, and Country, 2022 – 2028
10.6. Europe Peptide Synthesis Market Dynamics – Trends
11. Asia-Pacific Peptide Synthesis Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Vaccines
11.1.2. Oncology
11.1.3. Others
11.2. Product Type Analysis, 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Peptide Synthesizers
11.2.2. Reagents
11.3. End User Type Analysis, 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Pharmaceutical and Biotechnology Companies
11.3.2. Contract Development and Manufacturing Organisation/ Contract Research Organisation
11.3.3. Academics and Research Institutes
11.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. Australia and New Zealand
11.4.5. Rest of Asia-Pacific
11.5. Asia-Pacific Peptide Synthesis Market – Opportunity Analysis Index, By Application, Product Type, End User, and Country, 2022 – 2028
11.6. Asia-Pacific Peptide Synthesis Market Dynamics – Trends
12. Latin America Peptide Synthesis Market Analysis, 2013 – 2013 – 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Vaccines
12.1.2. Oncology
12.1.3. Others
12.2. Product Type Analysis, 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Peptide Synthesizers
12.2.2. Reagents
12.3. End User Type Analysis, 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Pharmaceutical and Biotechnology Companies
12.3.2. Contract Development and Manufacturing Organisation/ Contract Research Organisation
12.3.3. Academics and Research Institutes
12.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Peptide Synthesis Market – Opportunity Analysis Index, By Application, Product Type, End User, and Country, 2022 – 2028
12.6. Latin America Peptide Synthesis Market Dynamics – Trends
13. Middle East and Africa Peptide Synthesis Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Vaccines
13.1.2. Oncology
13.1.3. Others
13.2. Product Type Analysis, 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Peptide Synthesizers
13.2.2. Reagents
13.3. End User Type Analysis, 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Pharmaceutical and Biotechnology Companies
13.3.2. Contract Development and Manufacturing Organisation/ Contract Research Organisation
13.3.3. Academics and Research Institutes
13.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. GCC Countries
13.4.2. Saudi Arabia
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Peptide Synthesis Market – Opportunity Analysis Index, By Application, Product Type, End User, and Country, 2022 – 2028
13.6. MEA Peptide Synthesis Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. CS Bio Company, Inc.
14.2.2. Biotage AB
14.2.3. Gyros Protein Technologies AB
14.2.4. AAPPTec
14.2.5. CEM Corporation
14.2.6. Intavis Bioanalytical Instruments AG
14.2.7. Activotec
14.2.8. MultiSynTech GmbH
15. Research Methodology
16. Key Assumptions and Acronyms

Report

Company Profile

  • CS Bio Company, Inc.
  • Biotage AB
  • Gyros Protein Technologies AB
  • AAPPTec
  • CEM Corporation
  • Intavis Bioanalytical Instruments AG
  • Activotec
  • MultiSynTech GmbH

Description

Peptide Synthesizers Market size was valued at USD 371.92 million in 2021 and is anticipated to grow to USD 581.78 million by 2028 growing at a CAGR of 6.6% during the forecast period 2022-2028. Peptide Synthesizers Market is chains of amino acids that make up the basic building blocks of all living things. Individual amino acids can be used to make in-vitro peptides, which are subsequently bound according to their desired sequence in a highly regulated environment. Previously, synthetic peptides were manufactured using the liquid phase method, which has mostly been replaced by the solid phase method. Prior to the introduction of peptide synthesiser devices, in-vitro peptide synthesis was a time-consuming process requiring a lot of resources, highly skilled operators, and a lot of complexity. Peptide synthesisers provide the capacity to synthesise and create complex peptides in a short amount of time, from the research stage through the manufacturing stage. Furthermore, modern peptide synthesisers are capable of simultaneously synthesising numerous peptides. Synthetic peptides are used in the research and design of enzymes, vaccines, and medicines, as well as to manufacture specific antibody epitopes and enzyme-binding sites. Over the forecast period of 2021 to 2027, this is projected to propel the global market for peptide synthesisers. Furthermore, the growing preference in the pharmaceutical sector for peptide therapies and biosimilars is expected to boost the market. Rising viral and parasite infections around the world, as well as the incidence of other chronic diseases, are projected to increase demand for cutting-edge diagnostic technologies that use specific antibodies. In vitro peptide synthesis is predicted to increase as a result, fueling the global market for peptide synthesisers in the coming years.

 

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX